Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 9OTHER_GOV 2INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 10Neoplasm Metastasis 2Vitamin D Deficiency 1Pulmonary Fibrosis 1Obesity 1Nutrition Disorders 1Breast Diseases 1

Interventions

Irinotecan 6S 1 (combination) 4Oxaliplatin 3palbociclib 2durvalumab 2Tamoxifen 2Radiation 2Erlotinib Hydrochloride 2Cetuximab 2Capecitabine 2tremelimumab 1trametinib 1titanium silicide 1sintilimab 1olaparib 1nilotinib 1glasdegib 1genexol-PM 1futibatinib 1dabrafenib 1ceritinib 1capmatinib 1anlotinib 1Temozolomide 1Talc 1Surgical Procedures, Operative 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm Metastasis × Tamoxifen × Clear all
NCT03423199 2024-03-22

PATHWAY

National Cancer Center, Japan

Phase 3 Unknown
180 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00532454 2010-02-10

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

National Cancer Center, Korea

Phase 2 Terminated
21 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡